patent

This is the second patent win for Sandoz in December 2017. Allergan is expected to file for rehearing within 30 days on patent ruling. Earlier in Dec., Sandoz also won a patent case against Amgen.

http://alph.st/bf3c0558 Lilly joins the migraine drug race with Novartis and Amgen, as FDA accepts to review Lilly's Galcanezumab. Already, Teva filed a lawsuit in October 2017, seeking to block Lilly's migraine drug to market in the U.S. The size of the migraine market is expected to more than...

Texas court says Allergan's Mohawk Tribe patent deal is invalid. Earlier, Mylan had fired back at rival Allergan's attempt to shield its patent for Restasis.

Texas court says Mohawk Tribe patent deal is not legit. "The Court has serious concerns about the legitimacy of the tactic that Allergan and the Tribe have employed," Judge William Bryson said in a memorandum opinion accompanying his decision.

Allergan reaches a settlement with InnoPharma, a subsidiary of Pfizer on Restasis patent. Out of the four contestants, Mylan, Teva and Akorn are still contesting the patents in the federal court. http://alph.st/b3437240

Lilly wins Alimta patent challenge. Also, Lilly had won Alimta patent battle against Actavis in July 2017.

After selling Restasis patent to Mohawk Indians, Allergan is playing against its opponent Shire. Shire's Xiidra vs. Allergan's Restasis. Who will win?

After selling Restasis patent to Mohawk Indians, Allergan is playing the game very well.

Four senators, including Sherrod Brown ask for investigation on Mohawk Tribe deal.

Allergan reaches a settlement with Famy Care and it will grant Famy Care a license to market generic version of Restasis in U.S. in 2024.

Romark is an interesting place, it has one product in 2 formulations since 2004. It is a private company so company books are not truly open. We believe what they tell us, or not. The patents are up and they have not moved ahead with any "new" product, just investigating a line extension which...

Cialis, a drug that is used to treat impotence, was given for a free trial for the first time users in 2004. Now the patent for Cialis expires earlier than the previous date.